Conference Call and Webcast Information
Favrille management will host a conference call today to discuss the fourth quarter and year end 2007 financial results at 5:00 p.m. Eastern Time. A live audio webcast of management's presentation will be available on the Investor Relations section of the Company's web site at http://www.favrille.com. Alternatively, callers may participate in the conference call by dialing (888) 713-4213 or (617) 213-4865, passcode 19388148. To pre-register for this call, please go to https://www.theconferencingservice.com/prereg/key.process?key=P9YHNKNHB. Callers who pre-register will be given a unique PIN to gain immediate access to the call and bypass the live operator. You may pre-register at any time, including up to and after the call start time. A telephone replay of the call will also be available for 48 hours. The telephone replay can be accessed by dialing (888) 286-8010 or (617) 801-6888, passcode 99385491.
About Favrille, Inc.
Favrille, Inc. is a biopharmaceutical company focused on the
development and commercialization of targeted immunotherapies for the
treatment of cancer and other diseases of the immune system. The Company's
lead product candidate, Specifid (mitumprotimut-T, formerly FavId), is
based upon unique genetic information extracted from a patient's tumor.
Specifid is currently under clinical investigation in a Phase 3
registration trial for patients with follicular B-cell NHL and Phase 2
clinical trials in other B-cell NHL indications. The Company is developing
additional applications based on its immunotherapy expertise and
proprietary cost-effective manu
|SOURCE Favrille, Inc.|
Copyright©2008 PR Newswire.
All rights reserved